
Overview
Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies.
Dr. Karakousis is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.
His clinical research consists of co-authoring 134 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Kaposi Sarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eric Engels is an Infectious Disease provider in Baltimore, Maryland. Dr. Engels is rated as an Advanced provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are Kaposi Sarcoma, HIV/AIDS, Hepatitis, and Mononucleosis.
Irini Sereti is an Infectious Disease provider in Bethesda, Maryland. Dr. Sereti is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are HIV/AIDS, Kaposi Sarcoma, Sepsis, Mycobacterium Avium Complex Infections, and Colonoscopy.
The Johns Hopkins Hospital
Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HIV/AIDSDr. Karakousis isDistinguished. Learn about HIV/AIDS.
- Advanced
- AIDS Dementia ComplexDr. Karakousis isAdvanced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Karakousis isAdvanced. Learn about AIDS Dysmorphic Syndrome.
- Hepatitis CDr. Karakousis isAdvanced. Learn about Hepatitis C.
- MyelitisDr. Karakousis isAdvanced. Learn about Myelitis.
- Experienced
- COVID-19Dr. Karakousis isExperienced. Learn about COVID-19.
- HepatitisDr. Karakousis isExperienced. Learn about Hepatitis.
- Hepatitis BDr. Karakousis isExperienced. Learn about Hepatitis B.
- Kaposi SarcomaDr. Karakousis isExperienced. Learn about Kaposi Sarcoma.
- Mycobacterium Avium Complex InfectionsDr. Karakousis isExperienced. Learn about Mycobacterium Avium Complex Infections.
- NeurosyphilisDr. Karakousis isExperienced. Learn about Neurosyphilis.
